{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:45:28Z","timestamp":1740141928294,"version":"3.37.3"},"reference-count":105,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["940758"],"award-info":[{"award-number":["940758"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Gene therapy has been a long lasting goal for scientists, and there are many optimal methods\nand tools to correct disease-causing mutations in humans. Recently, the Clustered Regularly Interspaced\nShort Palindromic Repeats (CRISPR) technology has been progressively adopted for the assessment\na treatment of human diseases, including thalassemia, Parkinson&amp;#039;s disease, cystic fibrosis,\nglaucoma, Huntington\u2019s disease, and Human Immunodeficiency Virus\/Acquired Immunodeficiency\nSyndrome (HIV\/AIDS). CRISPR sequences belong to the bacterial immune system, which includes the\nnuclease Cas enzyme and an RNA sequence. The RNA sequence is unique and pathogen-specific, and\nidentifies and binds to the DNA of invasive viruses, allowing the nuclease Cas enzyme to cut the identified\nDNA and destroy the invasive viruses. This feature provides the possibility to edit mutations in\nthe DNA sequence of live cells by replacing a specific targeted RNA sequence with the RNA sequence\nin the CRISPR system. Previous studies have reported the improvement steps in confrontation with\nhuman diseases caused by single-nucleotide mutations using this system. In this review, we first introduce\nCRISPR and its functions and then elaborate on the use of CRISPR in the treatment of human\ndiseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201021666200621161610","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T07:52:21Z","timestamp":1592812341000},"page":"468-479","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CRISPR Genome Editing Technology and its Application in Genetic Diseases: A Review"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3867-580X","authenticated-orcid":true,"given":"Sepideh","family":"Khatibi","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-1444","authenticated-orcid":true,"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6093-7837","authenticated-orcid":true,"given":"Seyed H.","family":"Aghaee-Bakhtiari","sequence":"additional","affiliation":[{"name":"Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ygeno.2012.11.001","volume":"101","author":"Bianco A.M.","year":"2013","unstructured":"Bianco A.M.; Marcuzzi A.; Zanin V.; Girardelli M.; Vuch J.; Crovella S.; Database tools in genetic diseases research. Genomics 2013,101(2),75-85","journal-title":"Genomics"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/gepi.22015","volume":"41","author":"Xu C.","year":"2017","unstructured":"Xu C.; Wu K.; Zhang J.G.; Shen H.; Deng H.W.; Low-, high-coverage, and two-stage DNA sequencing in the design of the genetic association study. Genet Epidemiol 2017,41(3),187-197","journal-title":"Genet Epidemiol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJMoa1300662","volume":"370","author":"Tebas P.","year":"2014","unstructured":"Tebas P.; Stein D.; Tang W.W.; Frank I.; Wang S.Q.; Lee G.; Spratt S.K.; Surosky R.T.; Giedlin M.A.; Nichol G.; Holmes M.C.; Gregory P.D.; Ando D.G.; Kalos M.; Collman R.G.; Binder-Scholl G.; Plesa G.; Hwang W.T.; Levine B.L.; June C.H.; Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 2014,370(10),901-910","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1128\/MCB.2.11.1372","volume":"2","author":"Folger K.R.","year":"1982","unstructured":"Folger K.R.; Wong E.A.; Wahl G.; Capecchi M.R.; Patterns of integration of DNA microinjected into cultured mammalian cells: evidence for homologous recombination between injected plasmid DNA molecules. Mol Cell Biol 1982,2(11),1372-1387","journal-title":"Mol Cell Biol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"Cox D.B.T.","year":"2015","unstructured":"Cox D.B.T.; Platt R.J.; Zhang F.; Therapeutic genome editing: prospects and challenges. Nat Med 2015,21(2),121-131","journal-title":"Nat Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/mt.2016.10","volume":"24","author":"Maeder M.L.","year":"2016","unstructured":"Maeder M.L.; Gersbach C.A.; Genome-editing technologies for gene and cell therapy. Mol Ther 2016,24(3),430-446","journal-title":"Mol Ther"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/cgt.2015.54","volume":"22","author":"Sachdeva M.","year":"2015","unstructured":"Sachdeva M.; Sachdeva N.; Pal M.; Gupta N.; Khan I.A.; Majumdar M.; Tiwari A.; CRISPR\/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer. Cancer Gene Ther 2015,22(11),509-517","journal-title":"Cancer Gene Ther"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/JB.169.12.5429-5433.1987","volume":"169","author":"Ishino Y.","year":"1987","unstructured":"Ishino Y.; Shinagawa H.; Makino K.; Amemura M.; Nakata A.; Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 1987,169(12),5429-5433","journal-title":"J Bacteriol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","volume":"43","author":"Jansen R.","year":"2002","unstructured":"Jansen R.; Embden J.D.; Gaastra W.; Schouls L.M.; Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 2002,43(6),1565-1575","journal-title":"Mol Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","volume":"151","author":"Bolotin A.","year":"2005","unstructured":"Bolotin A.; Quinquis B.; Sorokin A.; Ehrlich S.D.; Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 2005,151(Pt 8),2551-2561","journal-title":"Microbiology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1099\/mic.0.27437-0","volume":"151","author":"Pourcel C.","year":"2005","unstructured":"Pourcel C.; Salvignol G.; Vergnaud G.; CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 2005,151(Pt 3),653-663","journal-title":"Microbiology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3389\/fphar.2017.00390","volume":"8","author":"Marson F.A.L.","year":"2017","unstructured":"Marson F.A.L.; Bertuzzo C.S.; Ribeiro J.D.; Personalized or precision medicine? The example of cystic fibrosis. Front Pharmacol 2017,8,390","journal-title":"Front Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cell.2015.12.041","volume":"164","author":"Lander E.S.","year":"2016","unstructured":"Lander E.S.; The Heroes of CRISPR. Cell 2016,164(1-2),18-28","journal-title":"Cell"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MOP.0000000000000418","volume":"28","author":"Botkin J.R.","year":"2016","unstructured":"Botkin J.R.; Ethical issues in pediatric genetic testing and screening. Curr Opin Pediatr 2016,28(6),700-704","journal-title":"Curr Opin Pediatr"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7536","DOI":"10.1073\/pnas.112047299","volume":"99","author":"Tang T-H.","year":"2002","unstructured":"Tang T-H.; Bachellerie J-P.; Rozhdestvensky T.; Bortolin M-L.; Huber H.; Drungowski M.; Elge T.; Brosius J.; H\u00fcttenhofer A.; Identification of 86 candidates for small non-messenger RNAs from the archaeon Archaeoglobus fulgidus. Proc Natl Acad Sci USA 2002,99(11),7536-7541","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2958.2004.04428.x","volume":"55","author":"Tang T.H.","year":"2005","unstructured":"Tang T.H.; Polacek N.; Zywicki M.; Huber H.; Brugger K.; Garrett R.; Bachellerie J.P.; H\u00fcttenhofer A.; Identification of novel non-coding RNAs as potential antisense regulators in the archaeon Sulfolobus solfataricus. Mol Microbiol 2005,55(2),469-481","journal-title":"Mol Microbiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"Jinek M.","year":"2012","unstructured":"Jinek M.; Chylinski K.; Fonfara I.; Hauer M.; Doudna J.A.; Charpentier E.; A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012,337(6096),816-821","journal-title":"Science"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1471-2105-8-172","volume":"8","author":"Grissa I.","year":"2007","unstructured":"Grissa I.; Vergnaud G.; Pourcel C.; The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 2007,8,172","journal-title":"BMC Bioinformatics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2009.12.033","volume":"37","author":"Karginov F.V.","year":"2010","unstructured":"Karginov F.V.; Hannon G.J.; The CRISPR system: small RNA-guided defense in bacteria and archaea. Mol Cell 2010,37(1),7-19","journal-title":"Mol Cell"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1126\/science.1159689","volume":"321","author":"Brouns S.J.","year":"2008","unstructured":"Brouns S.J.; Jore M.M.; Lundgren M.; Westra E.R.; Slijkhuis R.J.; Snijders A.P.; Dickman M.J.; Makarova K.S.; Koonin E.V.; van der Oost J.; Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008,321(5891),960-964","journal-title":"Science"},{"year":"2008","author":"Marraffini L. A.","unstructured":"Marraffini L. A.; Sontheimer E. J.;  2008","key":"ref=21"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1261\/rna.1246808","volume":"14","author":"Hale C.","year":"2008","unstructured":"Hale C.; Kleppe K.; Terns R.M.; Terns M.P.; Prokaryotic silencing (psi)RNAs in Pyrococcus furiosus. RNA 2008,14(12),2572-2579","journal-title":"RNA"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1155\/2006\/542818","volume":"2","author":"Lillest\u00f8l R.K.","year":"2006","unstructured":"Lillest\u00f8l R.K.; Redder P.; Garrett R.A.; Br\u00fcgger K.; A putative viral defence mechanism in archaeal cells. Archaea 2006,2(1),59-72","journal-title":"Archaea"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2958.2009.06641.x","volume":"72","author":"Lillest\u00f8l R.K.","year":"2009","unstructured":"Lillest\u00f8l R.K.; Shah S.A.; Br\u00fcgger K.; Redder P.; Phan H.; Christiansen J.; Garrett R.A.; CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and dynamic properties. Mol Microbiol 2009,72(1),259-272","journal-title":"Mol Microbiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tibs.2009.05.002","volume":"34","author":"van der Oost J.","year":"2009","unstructured":"van der Oost J.; Jore M.M.; Westra E.R.; Lundgren M.; Brouns S.J.; CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem Sci 2009,34(8),401-407","journal-title":"Trends Biochem Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"Wang T.","year":"2014","unstructured":"Wang T.; Wei J.J.; Sabatini D.M.; Lander E.S.; Genetic screens in human cells using the CRISPR-Cas9 system. Science 2014,343(6166),80-84","journal-title":"Science"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"Shalem O.","year":"2014","unstructured":"Shalem O.; Sanjana N.E.; Hartenian E.; Shi X.; Scott D.A.; Mikkelson T.; Heckl D.; Ebert B.L.; Root D.E.; Doench J.G.; Zhang F.; Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014,343(6166),84-87","journal-title":"Science"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"Barrangou R.","year":"2007","unstructured":"Barrangou R.; Fremaux C.; Deveau H.; Richards M.; Boyaval P.; Moineau S.; Romero D.A.; Horvath P.; CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007,315(5819),1709-1712","journal-title":"Science"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/JB.185.8.2410-2417.2003","volume":"185","author":"Peng X.","year":"2003","unstructured":"Peng X.; Br\u00fcgger K.; Shen B.; Chen L.; She Q.; Garrett R.A.; Genus-specific protein binding to the large clusters of DNA repeats (short regularly spaced repeats) present in Sulfolobus genomes. J Bacteriol 2003,185(8),2410-2417","journal-title":"J Bacteriol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1128\/JB.01412-07","volume":"190","author":"Deveau H.","year":"2008","unstructured":"Deveau H.; Barrangou R.; Garneau J.E.; Labont\u00e9 J.; Fremaux C.; Boyaval P.; Romero D.A.; Horvath P.; Moineau S.; Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 2008,190(4),1390-1400","journal-title":"J Bacteriol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1128\/JB.01415-07","volume":"190","author":"Horvath P.","year":"2008","unstructured":"Horvath P.; Romero D.A.; Co\u00fbt\u00e9-Monvoisin A-C.; Richards M.; Deveau H.; Moineau S.; Boyaval P.; Fremaux C.; Barrangou R.; Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J Bacteriol 2008,190(4),1401-1412","journal-title":"J Bacteriol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1099\/mic.0.023960-0","volume":"155","author":"Mojica F.J.M.","year":"2009","unstructured":"Mojica F.J.M.; D\u00edez-Villase\u00f1or C.; Garc\u00eda-Mart\u00ednez J.; Almendros C.; Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 2009,155(Pt 3),733-740","journal-title":"Microbiology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.febslet.2009.01.024","volume":"583","author":"Han D.","year":"2009","unstructured":"Han D.; Krauss G.; Characterization of the endonuclease SSO2001 from Sulfolobus solfataricus P2. FEBS Lett 2009,583(4),771-776","journal-title":"FEBS Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"Hsu P.D.","year":"2014","unstructured":"Hsu P.D.; Lander E.S.; Zhang F.; Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014,157(6),1262-1278","journal-title":"Cell"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"Ran F.A.","year":"2013","unstructured":"Ran F.A.; Hsu P.D.; Wright J.; Agarwala V.; Scott D.A.; Zhang F.; Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013,8(11),2281-2308","journal-title":"Nat Protoc"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nbt.2908","volume":"32","author":"Tsai S.Q.","year":"2014","unstructured":"Tsai S.Q.; Wyvekens N.; Khayter C.; Foden J.A.; Thapar V.; Reyon D.; Goodwin M.J.; Aryee M.J.; Joung J.K.; Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 2014,32(6),569-576","journal-title":"Nat Biotechnol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nbt.2909","volume":"32","author":"Guilinger J.P.","year":"2014","unstructured":"Guilinger J.P.; Thompson D.B.; Liu D.R.; Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol 2014,32(6),577-582","journal-title":"Nat Biotechnol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nbt.2889","volume":"32","author":"Wu X.","year":"2014","unstructured":"Wu X.; Scott D.A.; Kriz A.J.; Chiu A.C.; Hsu P.D.; Dadon D.B.; Cheng A.W.; Trevino A.E.; Konermann S.; Chen S.; Jaenisch R.; Zhang F.; Sharp P.A.; Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol 2014,32(7),670-676","journal-title":"Nat Biotechnol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nmeth.2681","volume":"10","author":"Esvelt K.M.","year":"2013","unstructured":"Esvelt K.M.; Mali P.; Braff J.L.; Moosburner M.; Yaung S.J.; Church G.M.; Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods 2013,10(11),1116-1121","journal-title":"Nat Methods"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","volume":"81","author":"Niewoehner J.","year":"2014","unstructured":"Niewoehner J.; Bohrmann B.; Collin L.; Urich E.; Sade H.; Maier P.; Rueger P.; Stracke J.O.; Lau W.; Tissot A.C.; Loetscher H.; Ghosh A.; Freskg\u00e5rd P.O.; Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 2014,81(1),49-60","journal-title":"Neuron"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nm0896-847","volume":"2","author":"Weatherall D.J.","year":"1996","unstructured":"Weatherall D.J.; Clegg J.B.; Thalassemia--a global public health problem. Nat Med 1996,2(8),847-849","journal-title":"Nat Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJM199907083410207","volume":"341","author":"Olivieri N.F.","year":"1999","unstructured":"Olivieri N.F.; The \u03b2-thalassemias. N Engl J Med 1999,341(2),99-109","journal-title":"N Engl J Med"},{"year":"2015","author":"Yanpanitch O.-u.","unstructured":"Yanpanitch O.-u.; Hatairaktham S.; Charoensakdi R.; Panichkul N.; Fucharoen S.; Srichairatanakool S.; Siritanaratkul N.; Kalpravidh R. W.;  2015","key":"ref=43"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ctim.2017.08.007","volume":"35","author":"Darvishi-Khezri H.","year":"2017","unstructured":"Darvishi-Khezri H.; Salehifar E.; Kosaryan M.; Karami H.; Alipour A.; Shaki F.; Aliasgharian A.; The impact of silymarin on antioxidant and oxidative status in patients with \u03b2-thalassemia major: A crossover, randomized controlled trial. Complement Ther Med 2017,35,25-32","journal-title":"Complement Ther Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13238-017-0475-6","volume":"8","author":"Liang P.","year":"2017","unstructured":"Liang P.; Ding C.; Sun H.; Xie X.; Xu Y.; Zhang X.; Sun Y.; Xiong Y.; Ma W.; Liu Y.; Wang Y.; Fang J.; Liu D.; Songyang Z.; Zhou C.; Huang J.; Correction of \u03b2-thalassemia mutant by base editor in human embryos. Protein Cell 2017,8(11),811-822","journal-title":"Protein Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1089\/hum.2017.210","volume":"29","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Wang Q.; Li Q.; Men K.; He Z.; Deng H.; Ji W.; Wei Y.; Recent advances in therapeutic genome editing in China. Hum Gene Ther 2018,29(2),136-145","journal-title":"Hum Gene Ther"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/aab6d6","volume":"15","author":"Bonomo M.E.","year":"2018","unstructured":"Bonomo M.E.; Deem M.W.; The physicist\u2019s guide to one of biotechnology\u2019s hottest new topics: CRISPR-Cas. Phys Biol 2018,15(4)","journal-title":"Phys Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.7150\/jca.22554","volume":"9","author":"Yang H.","year":"2018","unstructured":"Yang H.; Jaeger M.; Walker A.; Wei D.; Leiker K.; Weitao T.; Break Breast Cancer Addiction by CRISPR\/Cas9 Genome Editing. J Cancer 2018,9(2),219-231","journal-title":"J Cancer"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"Siegel R.L.","year":"2017","unstructured":"Siegel R.L.; Miller K.D.; Fedewa S.A.; Ahnen D.J.; Meester R.G.S.; Barzi A.; Jemal A.; Colorectal cancer statistics, 2017. CA Cancer J Clin 2017,67(3),177-193","journal-title":"CA Cancer J Clin"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nm.3802","volume":"21","author":"Matano M.","year":"2015","unstructured":"Matano M.; Date S.; Shimokawa M.; Takano A.; Fujii M.; Ohta Y.; Watanabe T.; Kanai T.; Sato T.; Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat Med 2015,21(3),256-262","journal-title":"Nat Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature11282","volume":"488","author":"Seshagiri S.","year":"2012","unstructured":"Seshagiri S.; Stawiski E.W.; Durinck S.; Modrusan Z.; Storm E.E.; Conboy C.B.; Chaudhuri S.; Guan Y.; Janakiraman V.; Jaiswal B.S.; Guillory J.; Ha C.; Dijkgraaf G.J.; Stinson J.; Gnad F.; Huntley M.A.; Degenhardt J.D.; Haverty P.M.; Bourgon R.; Wang W.; Koeppen H.; Gentleman R.; Starr T.K.; Zhang Z.; Largaespada D.A.; Wu T.D.; de Sauvage F.J.; Recurrent R-spondin fusions in colon cancer. Nature 2012,488(7413),660-664","journal-title":"Nature"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2012.12.006","volume":"86","author":"Willett C.G.","year":"2013","unstructured":"Willett C.G.; Chang D.T.; Czito B.G.; Meyer J.; Wo J.; Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012.(5). Int J Radiat Oncol Biol Phys 2013,86(1),330","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"Sato T.","year":"2009","unstructured":"Sato T.; Vries R.G.; Snippert H.J.; van de Wetering M.; Barker N.; Stange D.E.; van Es J.H.; Abo A.; Kujala P.; Peters P.J.; Clevers H.; Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009,459(7244),262-265","journal-title":"Nature"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature09637","volume":"469","author":"Sato T.","year":"2011","unstructured":"Sato T.; van Es J.H.; Snippert H.J.; Stange D.E.; Vries R.G.; van den Born M.; Barker N.; Shroyer N.F.; van de Wetering M.; Clevers H.; Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011,469(7330),415-418","journal-title":"Nature"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1234852","volume":"340","author":"Sato T.","year":"2013","unstructured":"Sato T.; Clevers H.; Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 2013,340(6137),1190-1194","journal-title":"Science"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.omtn.2017.06.006","volume":"8","author":"Jubair L.","year":"2017","unstructured":"Jubair L.; McMillan N.A.J.; The Therapeutic Potential of CRISPR\/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System. Mol Ther Nucleic Acids 2017,8,56-63","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2016.07.004","volume":"63","author":"Tycko J.","year":"2016","unstructured":"Tycko J.; Myer V.E.; Hsu P.D.; Methods for optimizing CRISPR-Cas9 genome editing specificity. Mol Cell 2016,63(3),355-370","journal-title":"Mol Cell"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"280","DOI":"10.15252\/embr.201439949","volume":"16","author":"Pagliarini R.","year":"2015","unstructured":"Pagliarini R.; Shao W.; Sellers W.R.; Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure. EMBO Rep 2015,16(3),280-296","journal-title":"EMBO Rep"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1590\/S0021-25712010000100002","volume":"46","author":"Fanales-Belasio E.","year":"2010","unstructured":"Fanales-Belasio E.; Raimondo M.; Suligoi B.; Butt\u00f2 S.; HIV virology and pathogenetic mechanisms of infection: a brief overview. Ann Ist Super Sanita 2010,46(1),5-14","journal-title":"Ann Ist Super Sanita"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3389\/fimmu.2017.01616","volume":"8","author":"Weatherley D.A.V.","year":"2017","unstructured":"Weatherley D.A.V.; Boswell M.T.; Rowland-Jones S.L.; Targeting TRIM5\u03b1 in HIV Cure Strategies for the CRISPR-Cas9 Era. Front Immunol 2017,8,1616","journal-title":"Front Immunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fpubh.2017.00032","volume":"5","author":"Zulfiqar H.F.","year":"2017","unstructured":"Zulfiqar H.F.; Javed A.; Sumbal; Afroze, B.; Ali, Q.; Akbar, K.; Nadeem, T.; Rana, M.A.; Nazar, Z.A.; Nasir, I.A.; Husnain, T. HIV diagnosis and treatment through advanced technologies. Front Public Health 2017,5,32","journal-title":"Front Public Health"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-4690-10-7","volume":"10","author":"Abecasis A.B.","year":"2013","unstructured":"Abecasis A.B.; Wensing A.M.; Paraskevis D.; Vercauteren J.; Theys K.; Van de Vijver D.A.; Albert J.; Asj\u00f6 B.; Balotta C.; Beshkov D.; Camacho R.J.; Clotet B.; De Gascun C.; Griskevicius A.; Grossman Z.; Hamouda O.; Horban A.; Kolupajeva T.; Korn K.; Kostrikis L.G.; K\u00fccherer C.; Liitsola K.; Linka M.; Nielsen C.; Otelea D.; Paredes R.; Poljak M.; Puchhammer-St\u00f6ckl E.; Schmit J.C.; S\u00f6nnerborg A.; Stanekova D.; Stanojevic M.; Struck D.; Boucher C.A.; Vandamme A.M.; HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology 2013,10(1),7","journal-title":"Retrovirology"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJMp1313771","volume":"370","author":"Fauci A.S.","year":"2014","unstructured":"Fauci A.S.; Marston H.D.; Ending AIDS--is an HIV vaccine necessary? N Engl J Med 2014,370(6),495-498","journal-title":"N Engl J Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","volume":"369","author":"Persaud D.","year":"2013","unstructured":"Persaud D.; Gay H.; Ziemniak C.; Chen Y.H.; Piatak M.; Chun T-W.; Strain M.; Richman D.; Luzuriaga K.; Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med 2013,369(19),1828-1835","journal-title":"N Engl J Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/srep02510","volume":"3","author":"Ebina H.","year":"2013","unstructured":"Ebina H.; Misawa N.; Kanemura Y.; Koyanagi Y.; Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 2013,3,2510","journal-title":"Sci Rep"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3892\/or.2015.4499","volume":"35","author":"Dong W.","year":"2016","unstructured":"Dong W.; Li B.; Wang J.; Song Y.; Zhang Z.; Fu C.; Zhang P.; Diagnostic and predictive significance of serum microRNA-7 in esophageal squamous cell carcinoma. Oncol Rep 2016,35(3),1449-1456","journal-title":"Oncol Rep"},{"key":"ref=67","first-page":"176","volume":"2","author":"Yaqoob A.","year":"2015","unstructured":"Yaqoob A.; Shehzad U.; Ahmad Z.; Naseer N.; Bashir S.; Effective treatment strategies against Ebola virus. Advancements in Life Sciences 2015,2(4),176-182","journal-title":"Advancements in Life Sciences"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.stemcr.2017.08.026","volume":"9","author":"Arias-Fuenzalida J.","year":"2017","unstructured":"Arias-Fuenzalida J.; Jarazo J.; Qing X.; Walter J.; Gomez-Giro G.; Nickels S.L.; Zaehres H.; Sch\u00f6ler H.R.; Schwamborn J.C.; FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson\u2019s Disease Modeling. Stem Cell Reports 2017,9(5),1423-1431","journal-title":"Stem Cell Reports"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ncomms1453","volume":"2","author":"Devine M.J.","year":"2011","unstructured":"Devine M.J.; Ryten M.; Vodicka P.; Thomson A.J.; Burdon T.; Houlden H.; Cavaleri F.; Nagano M.; Drummond N.J.; Taanman J-W.; Schapira A.H.; Gwinn K.; Hardy J.; Lewis P.A.; Kunath T.; Parkinson\u2019s disease induced pluripotent stem cells with triplication of the \u03b1-synuclein locus. Nat Commun 2011,2,440","journal-title":"Nat Commun"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"Bendor J.T.","year":"2013","unstructured":"Bendor J.T.; Logan T.P.; Edwards R.H.; The function of \u03b1-synuclein. Neuron 2013,79(6),1044-1066","journal-title":"Neuron"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.stem.2014.04.020","volume":"15","author":"Veres A.","year":"2014","unstructured":"Veres A.; Gosis B.S.; Ding Q.; Collins R.; Ragavendran A.; Brand H.; Erdin S.; Cowan C.A.; Talkowski M.E.; Musunuru K.; Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell 2014,15(1),27-30","journal-title":"Cell Stem Cell"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Ley T.J.","year":"2013","unstructured":"Ley T.J.; Miller C.; Ding L.; Raphael B.J.; Mungall A.J.; Robertson A.; Hoadley K.; Triche T.J.; Laird P.W.; Baty J.D.; Fulton L.L.; Fulton R.; Heath S.E.; Kalicki-Veizer J.; Kandoth C.; Klco J.M.; Koboldt D.C.; Kanchi K.L.; Kulkarni S.; Lamprecht T.L.; Larson D.E.; Lin L.; Lu C.; McLellan M.D.; McMichael J.F.; Payton J.; Schmidt H.; Spencer D.H.; Tomasson M.H.; Wallis J.W.; Wartman L.D.; Watson M.A.; Welch J.; Wendl M.C.; Ally A.; Balasundaram M.; Birol I.; Butterfield Y.; Chiu R.; Chu A.; Chuah E.; Chun H.J.; Corbett R.; Dhalla N.; Guin R.; He A.; Hirst C.; Hirst M.; Holt R.A.; Jones S.; Karsan A.; Lee D.; Li H.I.; Marra M.A.; Mayo M.; Moore R.A.; Mungall K.; Parker J.; Pleasance E.; Plettner P.; Schein J.; Stoll D.; Swanson L.; Tam A.; Thiessen N.; Varhol R.; Wye N.; Zhao Y.; Gabriel S.; Getz G.; Sougnez C.; Zou L.; Leiserson M.D.; Vandin F.; Wu H.T.; Applebaum F.; Baylin S.B.; Akbani R.; Broom B.M.; Chen K.; Motter T.C.; Nguyen K.; Weinstein J.N.; Zhang N.; Ferguson M.L.; Adams C.; Black A.; Bowen J.; Gastier-Foster J.; Grossman T.; Lichtenberg T.; Wise L.; Davidsen T.; Demchok J.A.; Shaw K.R.; Sheth M.; Sofia H.J.; Yang L.; Downing J.R.; Eley G.; Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013,368(22),2059-2074","journal-title":"N Engl J Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2017.06.006","volume":"54","author":"Lucas D.","year":"2017","unstructured":"Lucas D.; O\u2019Leary H.A.; Ebert B.L.; Cowan C.A.; Tremblay C.S.; Utility of CRISPR\/Cas9 systems in hematology research. Exp Hematol 2017,54,1-3","journal-title":"Exp Hematol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1182\/blood-2014-06-582809","volume":"124","author":"Bejar R.","year":"2014","unstructured":"Bejar R.; Lord A.; Stevenson K.; Bar-Natan M.; P\u00e9rez-Ladaga A.; Zaneveld J.; Wang H.; Caughey B.; Stojanov P.; Getz G.; Garcia-Manero G.; Kantarjian H.; Chen R.; Stone R.M.; Neuberg D.; Steensma D.P.; Ebert B.L.; TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients. Blood 2014,124(17),2705-2712","journal-title":"Blood"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1378\/chest.06-2085","volume":"131","author":"Grasemann H.","year":"2007","unstructured":"Grasemann H.; Stehling F.; Brunar H.; Widmann R.; Laliberte T.W.; Molina L.; D\u00f6ring G.; Ratjen F.; Inhalation of Moli1901 in patients with cystic fibrosis. Chest 2007,131(5),1461-1466","journal-title":"Chest"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","volume":"13","author":"Schwank G.","year":"2013","unstructured":"Schwank G.; Koo B-K.; Sasselli V.; Dekkers J.F.; Heo I.; Demircan T.; Sasaki N.; Boymans S.; Cuppen E.; van der Ent C.K.; Nieuwenhuis E.E.; Beekman J.M.; Clevers H.; Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 2013,13(6),653-658","journal-title":"Cell Stem Cell"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"Riordan J.R.","year":"1989","unstructured":"Riordan J.R.; Rommens J.M.; Kerem B.; Alon N.; Rozmahel R.; Grzelczak Z.; Zielenski J.; Lok S.; Plavsic N.; Chou J-L.; Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989,245(4922),1066-1073","journal-title":"Science"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.2570460","volume":"245","author":"Kerem B.","year":"1989","unstructured":"Kerem B.; Rommens J.M.; Buchanan J.A.; Markiewicz D.; Cox T.K.; Chakravarti A.; Buchwald M.; Tsui L-C.; Identification of the cystic fibrosis gene: genetic analysis. Science 1989,245(4922),1073-1080","journal-title":"Science"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/cpt.548","volume":"101","author":"Schneider E.K.","year":"2017","unstructured":"Schneider E.K.; Reyes-Ortega F.; Li J.; Velkov T.; Can cystic fibrosis patients finally catch a breath with lumacaftor\/ivacaftor? Clin Pharmacol Ther 2017,101(1),130-141","journal-title":"Clin Pharmacol Ther"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12967-017-1193-9","volume":"15","author":"Rafeeq M.M.","year":"2017","unstructured":"Rafeeq M.M.; Murad H.A.S.; Cystic fibrosis: current therapeutic targets and future approaches. J Transl Med 2017,15(1),84","journal-title":"J Transl Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"Hoffman E.P.","year":"1987","unstructured":"Hoffman E.P.; Brown R.H.; Kunkel L.M.; Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987,51(6),919-928","journal-title":"Cell"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"Emery A.E.","year":"1991","unstructured":"Emery A.E.; Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul Disord 1991,1(1),19-29","journal-title":"Neuromuscul Disord"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/mus.1192","volume":"24","author":"Rando T.A.","year":"2001","unstructured":"Rando T.A.; The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 2001,24(12),1575-1594","journal-title":"Muscle Nerve"},{"key":"ref=84","author":"Gee P.","year":"2017","unstructured":"Gee P.; Xu H.; Hotta A.;  Cellular reprogramming, genome editing, and alternative CRISPR Cas9 technologies for precise gene therapy of Duchenne muscular dystrophy 2017","journal-title":"Cellular reprogramming, genome editing, and alternative CRISPR Cas9 technologies for precise gene therapy of Duchenne muscular dystrophy"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/343180a0","volume":"343","author":"England S.B.","year":"1990","unstructured":"England S.B.; Nicholson L.V.; Johnson M.A.; Forrest S.M.; Love D.R.; Zubrzycka-Gaarn E.E.; Bulman D.E.; Harris J.B.; Davies K.E.; Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 1990,343(6254),180-182","journal-title":"Nature"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1212\/WNL.51.2.592","volume":"51","author":"Mirabella M.","year":"1998","unstructured":"Mirabella M.; Galluzzi G.; Manfredi G.; Bertini E.; Ricci E.; De Leo R.; Tonali P.; Servidei S.; Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy. Neurology 1998,51(2),592-595","journal-title":"Neurology"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","volume":"86","author":"Gloss D.","year":"2016","unstructured":"Gloss D.; Moxley R.T.; Ashwal S.; Oskoui M.; Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016,86(5),465-472","journal-title":"Neurology"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nmd.2014.11.011","volume":"25","author":"Haas M.","year":"2015","unstructured":"Haas M.; Vlcek V.; Balabanov P.; Salmonson T.; Bakchine S.; Markey G.; Weise M.; Schlosser-Weber G.; Brohmann H.; Yerro C.P.; Mendizabal M.R.; Stoyanova-Beninska V.; Hillege H.L.; European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene. Neuromuscul Disord 2015,25(1),5-13","journal-title":"Neuromuscul Disord"},{"year":"2017","author":"Aartsma-Rus A.","unstructured":"Aartsma-Rus A.; Krieg A. M.;  2017","key":"ref=89"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/dgd.12107","volume":"56","author":"Li H.L.","year":"2014","unstructured":"Li H.L.; Nakano T.; Hotta A.; Genetic correction using engineered nucleases for gene therapy applications. Dev Growth Differ 2014,56(1),63-77","journal-title":"Dev Growth Differ"},{"key":"ref=91","first-page":"122","volume":"35","author":"Bello L.","year":"2016","unstructured":"Bello L.; Pegoraro E.; Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy. Acta Myol 2016,35(3),122-127","journal-title":"Acta Myol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"11199","DOI":"10.1073\/pnas.1706193114","volume":"114","author":"Jain A.","year":"2017","unstructured":"Jain A.; Zode G.; Kasetti R.B.; Ran F.A.; Yan W.; Sharma T.P.; Bugge K.; Searby C.C.; Fingert J.H.; Zhang F.; Clark A.F.; Sheffield V.C.; CRISPR-Cas9-based treatment of myocilin-associated glaucoma. Proc Natl Acad Sci USA 2017,114(42),11199-11204","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.2013.5099","volume":"309","author":"Hollands H.","year":"2013","unstructured":"Hollands H.; Johnson D.; Hollands S.; Simel D.L.; Jinapriya D.; Sharma S.; Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA 2013,309(19),2035-2042","journal-title":"JAMA"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"Weinreb R.N.","year":"2014","unstructured":"Weinreb R.N.; Aung T.; Medeiros F.A.; The pathophysiology and treatment of glaucoma: a review. JAMA 2014,311(18),1901-1911","journal-title":"JAMA"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s003359900844","volume":"9","author":"Abderrahim H.","year":"1998","unstructured":"Abderrahim H.; Jaramillo-Babb V.L.; Zhou Z.; Vollrath D.; Characterization of the murine TIGR\/myocilin gene. Mamm Genome 1998,9(8),673-675","journal-title":"Mamm Genome"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1126\/science.275.5300.668","volume":"275","author":"Stone E.M.","year":"1997","unstructured":"Stone E.M.; Fingert J.H.; Alward W.L.; Nguyen T.D.; Polansky J.R.; Sunden S.L.; Nishimura D.; Clark A.F.; Nystuen A.; Nichols B.E.; Mackey D.A.; Ritch R.; Kalenak J.W.; Craven E.R.; Sheffield V.C.; Identification of a gene that causes primary open angle glaucoma. Science 1997,275(5300),668-670","journal-title":"Science"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1167\/iovs.11-8837","volume":"53","author":"Zode G.S.","year":"2012","unstructured":"Zode G.S.; Bugge K.E.; Mohan K.; Grozdanic S.D.; Peters J.C.; Koehn D.R.; Anderson M.G.; Kardon R.H.; Stone E.M.; Sheffield V.C.; Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2012,53(3),1557-1565","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1172\/JCI82799","volume":"125","author":"Zode G.S.","year":"2015","unstructured":"Zode G.S.; Kuehn M.H.; Nishimura D.Y.; Searby C.C.; Mohan K.; Grozdanic S.D.; Bugge K.; Anderson M.G.; Clark A.F.; Stone E.M.; Sheffield V.C.; Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest 2015,125(8),3303-3303","journal-title":"J Clin Invest"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40484-014-0030-x","volume":"2","author":"Wu X.","year":"2014","unstructured":"Wu X.; Kriz A.J.; Sharp P.A.; Target specificity of the CRISPR-Cas9 system. Quant Biol 2014,2(2),59-70","journal-title":"Quant Biol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ncl.2014.09.003","volume":"33","author":"Dayalu P.","year":"2015","unstructured":"Dayalu P.; Albin R.L.; Huntington disease: pathogenesis and treatment. Neurol Clin 2015,33(1),101-114","journal-title":"Neurol Clin"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"Vonsattel J.P.G.","year":"1998","unstructured":"Vonsattel J.P.G.; DiFiglia M.; Huntington disease. J Neuropathol Exp Neurol 1998,57(5),369-384","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133709","volume":"10","author":"Despard J.","year":"2015","unstructured":"Despard J.; Ternes A-M.; Dimech-Betancourt B.; Poudel G.; Churchyard A.; Georgiou-Karistianis N.; Characterising Upper Limb Movements in Huntington\u2019s Disease and the Impact of Restricted Visual Cues. PLoS One 2015,10(8)","journal-title":"PLoS One"},{"key":"ref=103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099341","volume":"9","author":"Drouet V.","year":"2014","unstructured":"Drouet V.; Ruiz M.; Zala D.; Feyeux M.; Auregan G.; Cambon K.; Troquier L.; Carpentier J.; Aubert S.; Merienne N.; Bourgois-Rocha F.; Hassig R.; Rey M.; Dufour N.; Saudou F.; Perrier A.L.; Hantraye P.; D\u00e9glon N.; Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells. PLoS One 2014,9(6)","journal-title":"PLoS One"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","volume":"25","author":"Monteys A.M.","year":"2017","unstructured":"Monteys A.M.; Ebanks S.A.; Keiser M.S.; Davidson B.L.; CRISPR\/Cas9 editing of the mutant huntingtin allele in vitro and in vivo. Mol Ther 2017,25(1),12-23","journal-title":"Mol Ther"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"Yang S.","year":"2017","unstructured":"Yang S.; Chang R.; Yang H.; Zhao T.; Hong Y.; Kong H.E.; Sun X.; Qin Z.; Jin P.; Li S.; Li X-J.; CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J Clin Invest 2017,127(7),2719-2724","journal-title":"J Clin Invest"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201021666200621161610","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182996\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201021666200621161610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T11:01:37Z","timestamp":1655809297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182996\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201021666200621161610","relation":{},"ISSN":["1389-2010"],"issn-type":[{"type":"print","value":"1389-2010"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}